1Takada C G, Salavati R, Altman S. Phenotypic conversion of drug-resistant bacteria to drug sensitivity[J]. Proc Natl Acad Sci USA, 1997,94(15):8468-8472.
2Sulakvelidze A, Alavidze Z, Glenn M J. Bacteriophage therapy[J]. Antimicro Agents Chemother, 2001, 45(4):649-659.
3Nelson D, Loomis L, Fischetti V A. Prevention and elimination of upper respiratory colonization of mice by group a streptococci by using a bacteriophage lytic enzyme[J]. Proc Nat Acad Sci USA, 2001,98(8):4107-4112.
4Wommack K E, Colwell R R. Microbiol[J]. Mol Biol Rev, 2000, 64(1):69-114.
5Ryland Y, Wang I N, Roof W D.Phages will out: strategies of host cell lysis[J]. Trends Microbiol, 2000,8(3):120-128.
6Bernhardt T, Wang I N, Struck D K, et al.A protein antibiotic in the phage Q virion: diversity in lysis targets[J]. Science, 2001,292:2326-2329.
7Wang I N, Smith D L, Ryland Y. Holins: the protein clocks of bacteriophage infections[J]. Ann Rev Microbiol, 2000,54(4):799-825.
8Bernhardt T G, Struck D K, Ryland Y. The lysis protein E of X174 is a specific inhibitor of the MraY-catalyzed step in peptidoglycan synthesis[J]. J Biol Chem, 2001,276(9):6093-6097.
9Bernhardt T G., Roof W D, Young R. Genetic evidence that the bacteriophage X174 lysis protein inhibits cell wall synthesis[J]. Proc Natl Acad Sci USA, 2000,97(8):4297-4302.
10Robert J H, Payne, V A A, Jansen J, et al. Understanding bacte-riophage therapy as a density-dependent kinetic process[J]. J Theor Biol, 2001,208(1):37-48.
